Nutraplus India commences commercial production at its Tarapur plant for anti-malarial drug LUMEFANTRINE

18 Jan 2016 Evaluate

Nutraplus India has commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE. Previously company was engaged in the manufacturing of Intermediate of the same drug (i.e. n-2 stage) at its existing factory and was selling to the various pharma companies.

Now company is manufacturing the final end product (i.e. LUMEFANTRINE) on full fledge basis at company's new production facilities. The company has obtained necessary approvals and has commenced the commercial production of LUMEFANTRINE. This is a forward integration and shall result in better margin. The company expects to achieving full production capacities in next 3 month in its plant.

Nutraplus India was incorporated as a private limited company in February 1990. The company’s manufacturing unit was commissioned to make APIs and intermediates. 

 

Nutraplus India Share Price

2.10 0.00 (0.00%)
13-Dec-2021 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×